Free Submission Public Relations &
Deutsch English

Onyx Pharmaceuticals: Company Analysis

Onyx Pharmaceuticals: Company Analysis - new company profile report published

Print article Print article
2013-01-24 07:52:54 - Onyx Pharmaceuticals: Company Analysis - a new company profile report on

This analysis evaluates the company´s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company´s historical and forecast financial performance. The report also gives an in-depth analysis of the company´s key prescription pharmaceutical product, and provides a forecast sales performance for this drug.

Report Scope

- Patient-based forecasts for Onyx´s lead pipeline candidate, Kyprolis (carfilzomib), supported by key opinion leader research
- Assessment of Onyx´s corporate strategy, operating performance, and earlier-stage pipeline

Key Highlights

In July 2012, the FDA granted accelerated approval for Onyx´s proteasome inhibitor Kyprolis for the treatment of patients with multiple myeloma who have received at least two prior therapies including Celgene´s Velcade and



an immunomodulatory agent and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Onyx expects to file Kyprolis for approval in the EU in 2013 based on the results of the Phase III ASPIRE trial.

Reasons to Buy

- Evaluate the prospects for Onyx´s three key products: Kyprolis, Nexavar, and regorafenib
- Assess hematologist-oncologists´ views in anticipation of Kyprolis´s launch

Click for report details: ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Company Profile Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact | BidVertiser